TerminatedPhase 3NCT00545597

A Phase III Trial of Lorenzo's Oil in Adrenomyeloneuropathy

Studying Neonatal adrenoleukodystrophy

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Principal Investigator
Gerald V Raymond, M.D.
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Intervention
Lorenzo's oil(drug)
Enrollment
240 enrolled
Eligibility
18 years · All sexes
Timeline
2005 – 2007

Study locations (1)

Collaborators

Food and Drug Administration (FDA)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00545597 on ClinicalTrials.gov

Other trials for Neonatal adrenoleukodystrophy

Additional recruiting or active studies for the same condition.

See all trials for Neonatal adrenoleukodystrophy →

← Back to all trials